Pharmacologic Manipulation of Sphingosine Kinase in Retinal Endothelial Cells: Implications for Angiogenic Ocular Diseases
Open Access
- 1 November 2006
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Opthalmology & Visual Science
- Vol. 47 (11) , 5022-5031
- https://doi.org/10.1167/iovs.05-1236
Abstract
Purpose. The increased vascular permeability and pathogenic angiogenesis observed in diabetic retinopathy are induced, at least in part, by local inflammation and vascular endothelial growth factor (VEGF). Therefore, inhibition of signaling from VEGF and tumor necrosis factor-α (TNFα) is a promising approach to the treatment of this disease, as well as ocular diseases with similar etiologies, including age-related macular degeneration. A growing body of evidence demonstrates that sphingosine kinase (SK) plays an important role in cellular proliferation and angiogenesis. This study was undertaken to examine the effects of SK inhibitors on the responses of retinal endothelial cells (RECs) to VEGF and TNFα and their therapeutic efficacy in a diabetic retinopathy model. methods. The expression and function of SK in bovine and human RECs were examined by immunoblot analysis. The involvement of SK in mediating responses to VEGF and TNFα was examined by using pharmacologic inhibitors of SK in cellular and in vivo assays, including a 3-month streptozotocin-induced diabetic retinopathy model in rats. results. SK was present and active in human and bovine RECs, and SK activity in these cells was stimulated by VEGF. Inhibitors of SK blocked VEGF-induced production of sphingosine 1-phosphate and markedly attenuated VEGF-induced proliferation and migration of RECs. In addition, SK inhibitors were shown to block TNFα-induced expression of adhesion proteins, suppress VEGF-induced vascular leakage in an in vivo mouse model, and reduce retinal vascular leakage in the rat diabetic retinopathy model. conclusions. Overall, these studies demonstrate that inhibitors of SK attenuate the effects of proliferative and inflammatory stimuli on RECs both in vitro and in vivo, and so could be significant therapeutics in the treatment of diabetic retinopathy.Keywords
This publication has 53 references indexed in Scilit:
- Suppression of Ulcerative Colitis in Mice by Orally Available Inhibitors of Sphingosine KinaseDigestive Diseases and Sciences, 2007
- Sphingosine 1-phosphate and its receptors: an autocrine and paracrine networkNature Reviews Immunology, 2005
- LPA and S1P Increase Corneal Epithelial and Endothelial Cell Transcellular ResistanceInvestigative Opthalmology & Visual Science, 2005
- The Ins2AkitaMouse as a Model of Early Retinal Complications in DiabetesInvestigative Opthalmology & Visual Science, 2005
- The role of growth factors in the pathogenesis of diabetic retinopathyExpert Opinion on Investigational Drugs, 2004
- Ocular neovascularisation and excessive vascular permeabilityExpert Opinion on Biological Therapy, 2004
- Sphingosine-1-phosphate: an enigmatic signalling lipidNature Reviews Molecular Cell Biology, 2003
- Ceramide Induction of COX-2 and PGE2 in Pulmonary A549 Cells Does Not Involve Activation of NF-κBBiochemical and Biophysical Research Communications, 2000
- Segmental Differentiation of Permeability, Protein Glycosylation, and Morphology of Cultured Bovine Lung Vascular EndotheliumBiochemical and Biophysical Research Communications, 1994
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990